Edgewise Therapeutics, Inc. financial statements
Edgewise Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 167.79M | 10-K |
| Cash and equivalents | USD 61.15M | 10-Q |
| Total debt | USD 3.99M | EODHD |
Edgewise Therapeutics, Inc. financials on 6ix · Edgewise Therapeutics, Inc. on 6ix